Clinical Trial Administrator (2 posts)

We have an exciting opportunity available for two Clinical Trial Administrators to join the Oncology Clinical Trials Office (OCTO), which forms part of the Department of Oncology and is also the oncology division of the UKCRC registered clinical trials unit, OCTRU (Oxford Clinical Trials Research Unit). OCTO has good working relationships with UK-wide study sites and international groups in Europe.
OCTO runs academic clinical trials to the highest standards and is proactive in improving clinical trial procedures and delivering high quality data.
You will provide support to a team of trial management professionals and will be involved in many aspects of clinical trial administration, such as study site set-up, corresponding with the regulatory bodies and R&D departments, handling clinical queries, checking trial data and organising trial meetings. Occasional travel will be required as part of this role.
You will be educated to A-level or equivalent in a biomedical or associated subject. You will have effective communication and inter-personal skills, as well as critical and intelligent attention to detail and high standards of accuracy. You will also have had experience of working to Good Clinical Practice guidelines and experience of UK clinical research structures, regulatory and ethical systems.
This is a full-time post, although part-time hours may be considered, and is available for 1 year in the first instance.
All applicants must complete a short application form and upload a CV and supporting statement.
The closing date for applications is 12.00 noon on 16 October 2017.

Closing Date: 
Monday, October 16, 2017 - 12:00
Organisation: 
Department of Oncology
About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
Research
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate training programmes for both scientists and clinicians are internationally recognised.